Skip to content

Cervical TsDCS on Stroke Patients

Clinical and Neurophysiological Evaluation of the Effects of Cervical TsDCS on Stroke Patients with Distal Upper Limb Strength Deficit

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06826274
Acronym
AMPLI-MOV
Enrollment
40
Registered
2025-02-13
Start date
2025-03-31
Completion date
2026-03-31
Last updated
2025-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Recovery, Motor Rehabilitation

Brief summary

The present project aims to evaluate the facilitatory modulation of motor responses of the limb upper limb by tsDCS in patients with arm/hand hyposthenia after cerebral ischemia to verify the possible therapeutic benefits that this type of stimulation can induce in terms of of strength, dexterity and effectiveness in acts of daily living.

Interventions

OTHERtDCS

Transcranial direct current stimulation

Sponsors

IRCCS San Raffaele Roma
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Group Stroke: Inclusion criteria: 1. age over 18 years; 2. first ischemic/hemorrhagic stroke (within 30 days of onset); 3. mild-to-moderate stroke (NIHSS scale score\<16). 4. residual function of the upper limb, assessed by the following scales: - MRC of the distal muscles of the upper limb: score between 2 and 4; - NHISS (items 5A and 5B): score between 1 and 3; 5. ability to give informed consent and understand instructions.

Exclusion criteria

1. severe spasticity (Ashworth Scale score \> 2); 2. severe aphasia; 3. severe neglect; 4. history of disabling neurological disease; 5. history of epilepsy; 6. significant comorbidities; 7. contraindications to tsDCS. Healthy Group: Inclusion criteria: 1. age over 18 years; 2. equalized in age with the patient group.

Design outcomes

Primary

MeasureTime frameDescription
improvement of paretic hand performancethrough study completion, an average of 1 yearThe primary outcome measure is the improvement in hand strength and dexterity in individuals with upper limb motor impairment following cerebral ischemia, after the application of tsDCS at the cervical spinal level during Reaching

Countries

Italy

Contacts

Primary ContactFabrizio Vecchio
fabrizio.vecchio@sanraffaele.it3478031201

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026